期刊文献+

CA125对子宫动脉栓塞术治疗子宫腺肌病疗效和复发的预测价值 被引量:2

暂未订购
导出
摘要 [目的]探讨采用子宫体积和血清CA125动态监测评价子宫动脉栓塞术治疗子宫腺肌病的疗效和复发的可行性。[方法]对78例子宫腺肌病患者进行子宫动脉栓塞治疗,在子宫动脉栓塞术术前及术后连续动态监测血清CA125和子宫体积的变化。[结果]子宫动脉栓塞术术后3周子宫体积和血清明显下降(P<0.01)。子宫动脉栓塞术后子宫缩小体积与CA125降低水平呈显著相关性,相关系数为0.55(P<0.05)。34例患者子宫动脉栓塞术后复发时子宫体积明显增大,CA125明显升高(P<0.05)。子宫动脉栓塞术后子宫增大体积与CA125升高水平呈显著相关性,相关系数为0.47,(P<0.05)。[结论]子宫动脉栓塞治疗子宫腺肌病术后,血清CA125水平动态监测在评价子宫腺肌病疗效及监测复发作为重要依据。
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2007年第B06期74-75,共2页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省卫生厅科研基金资助项目(A2006188)
  • 相关文献

参考文献5

二级参考文献14

  • 1伍俊萍,张惜阴.CA125与子宫内膜异位症的关系[J].国外医学(妇产科学分册),1996,23(2):72-75. 被引量:22
  • 2Barbieri RL.CA125 in patients with endometriosis[J].Fertil Steril,1986,45(6):767-769.
  • 3Krasnicki D.Serum and peritoneal fluid CA125 concentration in women with endometriosis[J].Ginekol Pol,2001,72(12):1365-1372.
  • 4Mathur S,Peress MR,Williamson HO,et al.Autoimmunity to endometrium and ovary in endometriosis[J].Clin Exp Immunol,1982,50(6):259-231.
  • 5Kaupp A,Jonath S.Changing concepts of medical treatment of endometriosis[J].Acta Obstet Gynecol Scand,1999,89(11):245-266.
  • 6Takahashi K,Kitao M,Okada S,et al.Serum CA125 and EMAb in evaluating patients with endometrioma prior to medical therapy[J].Fertil Steril,1996,65(1):288-292.
  • 7连利娟 胡秀风 刘文淑.卵巢癌克隆抗体在诊断上的应用[J].中华妇产科杂志,1985,20(5):257-257.
  • 8McBean JH,Brumsted JR. In vitro CA125 seretion by endometrium from women with advanced endometriosis. Fertil Steril, 1993,59 ( 1 ) :89.
  • 9Barbieri RL. CA125 in patients with endometriosis. Fertil Steril,1986,45(6) :70.
  • 10Kobagash H, Ida W, Terao T, et al. Molecular characteristics of the CA125 antigen produced by humen endometrial epithelial cells:comparison between eutopic and heterotopic epithelium. Am J Obstet Gynecol,1993,169 (3) :725.

共引文献27

同被引文献22

  • 1Giuseppe B, Brosens I, Carrara S. Adenomyosis:new knowledge is generating new treatment strategies [ J ]. Womens Health, 2009,5 (3) :297-311.
  • 2Marco T, Luca B, Marco C, et al. Elastosonography: a possible new tool for diagnosis of adenomyosis [ J ]. Eur Radiol, 2011,21 (7) : 1546-1552.
  • 3Takahashi K, Kijima S, Yoshino K, et al. Differentral diagnosis between leiomyoma uteri and adenomyosis using CA125 a new tumor marker of ovarian carcinoma [ J ]. Nippon Sanka Fujinka Gakkai Zasshi, 1985,37(4) :591-595.
  • 4Krasnieki D. Serum and peritoneal fluid CA125 concentration in women with endometriosis [ J ]. Ginekol Pol, 2001,72 ( 12A ) : 1365-1367.
  • 5Lee CK, Friedlander M, Brown C, et al. Early decline in cancer antigen 125 a surrogate for progression-free survival in recurrent o- varian cancer[J]. J Natl Cancer lnst, 2011,103(17) :1338-1342.
  • 6Wang PH, Liu WM, Fuh JL, et al. Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma[ J]. Fertil Steril, 2009,92(3 ): 876-885.
  • 7Katz A. Sexuality after hysterectomy [ J ]. J Obstet Gynecol Neo- natal Nurs, 2002,31 (3) :256-262.
  • 8Kim MD, Won JW, Lee DY, et al. Uterine artery embolization for adenomyosis without fibroids[J]. Clin Radiol, 2004, 59(6): 520-526.
  • 9Kim MD, Kim S, Kim NK, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis[J]. AJR Am J Roentgenol, 2007,188(1): 176-181.
  • 10Pepas L, Deguara C, Davis C. Update on the surgical management of adenomyosis[J]. Curr Opin Obstet Gynecol, 2012, 24(4): 259-264.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部